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Macrophages and hypoxia in 
human chronic kidney disease
Lars-Peter Erwig1
Chronic kidney disease is characterized by progressive interstitial 
fibrosis, reduced blood flow, and tubular atrophy, which present a 
common pathway of destruction irrespective of the initial underlying 
pathology. There is comprehensive evidence that the interactions of 
infiltrating macrophages with resident tissue cells play a critical role 
in this process. A new study now describes the correlation between 
macrophages, capillary density, and interstitial scarring and suggests 
distinct differences in early and advanced renal disease.
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Renal disease has a wide spectrum of 
histological patterns, suggesting a vari-
ety of immunopathogenetic mecha-
nisms of injury. Not all renal diseases 
lead to end-stage renal failure, but those 
that do are characterized by progressive 
renal scarring. Macrophages have been 
extensively studied in this context and 
play an important role in the initiation 
and progression of renal fibrosis.1 Pro-
gressive tubulointerstitial disease is 
associated with loss of interstitial cap-
illaries and reduced blood flow, which 
suggests that the renal cortex becomes 
more ischemic as chronic kidney dis-
ease evolves.
A new study by Eardley et al.2 (this 
issue) examines the relationship 
between hypoxia and inflammation 
in chronic kidney disease. This study 
investigates whether there is a clinical 
correlation between interstitial capil-
lary density, macrophage numbers, 
albuminuria, and monocyte chem-
oattractant protein-1 (MCP-1)/CCL2 
urinary excretion in renal biopsies of 
patients with early and advanced renal 
disease. The main finding of the study 
is that in patients with limited renal 
scarring there was a strong association 
between capillary density, macrophage 
infiltration, and chronic damage but no 
correlation between capillary density 
and macrophage numbers. In keeping 
with the group’s previous work,3 there 
was, however, a strong association of 
albuminuria with macrophage numbers 
(and MCP-1/CCL2 levels), which sug-
gests that this is an important mecha-
nism for macrophage recruitment in 
patients with limited disease.
In contrast, in patients with more 
severe scarring there was a strong cor-
relation between capillary density, mac-
rophage numbers, and chronic damage 
but no association between capillary 
density and MCP-1/CCL2, which sug-
gests that the dominant pathway for 
macrophage recruitment and prolif-
eration in this setting is MCP-1/CCL2 
independent.
A smal l  number of  studies  in 
experimental models have previously 
demonstrated an association between 
tubulointerstitial hypoxia and pro-
gressive injury4 despite the obvious 
difficulties of quantifying tissue oxy-
genation at the cellular level. In the new 
study by Eardley et al.2 (which used 
biopsies from patients with chronic 
kidney disease), hypoxia cannot be 
assessed directly, but the authors pro-
vide strands of evidence that suggest 
worsening interstitial hypoxia in 
advanced disease. This is achieved by 
immunohisto chemistry to assess capil-
lary density combined with validated 
indirect markers of tissue hypoxia such 
as vascular endothelial growth factor, 
a hypoxia-induced angiogenic factor, 
and carbonic anhydrase IX, a trans-
membrane glycoprotein that is hypoxia 
inducible. Despite the need to detect 
tissue hypoxia in vivo, there are few 
methods available, and most studies 
examining renal tissue have relied on 
chemical tools such as pimonidazole, 
which is also extensively used to detect 
hypoxic tumor cells in vivo.5 More 
complex approaches, such as a hypoxia-
sensing transgenic rat,4 and imaging 
techniques, such as blood oxygen level-
dependent magnetic resonance imag-
ing,6 have been used and offer scope 
for future development. Hypoxia, as is 
mentioned above, can also be assessed 
indirectly by detection of the large 
number of genes that are upregulated 
in response to hypoxia. The family of 
hypoxia-inducible transcription factors 
(HIF), the most extensively studied, is 
upregulated in the kidney in response 
to hypoxia, and pharmacological HIF 
stabilization has been shown to con-
fer tissue protection in experimental 
models.7 Systems biology approaches 
may prove highly useful to identify 
other genes that are upregulated in 
renal hypoxia and, possibly more 
importantly, to identify genes that are 
repressed in hypoxic conditions, and 
the inhibition of certain gene products 
may ultimately turn out to be critical 
for the progression of renal injury in 
hypoxic conditions.
The study by Eardley et al.2 is 
observational and associative, but 
nevertheless significant for our under-
standing of the evolution of renal 
injury. Hypoxic damage secondary to 
obliteration of the interstitial capillary 
bed may represent an important path-
way in human chronic kidney disease 
for the recruitment and in situ reten-
tion and proliferation of macrophages, 
the dominant infiltrating cell in the 
progression of chronic kidney disease. 
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Oxygen consumption by macrophages 
may exacerbate hypoxia, whereas 
the multitude of secretory molecules 
induced in macrophages encountering 
hypoxic conditions may contribute to 
cell survival. This study, in conjunction 
with the overwhelming evidence from 
experimental models showing that 
macrophages within the inflamed kid-
ney are heterogeneous depending on 
the mode of recruitment and the micro-
environment they encounter,8,9 raises 
important questions. What are the 
chemotactic factors that drive macro-
phage recruitment in advanced disease, 
and what are the functional proper-
ties of macrophages that have been 
recruited through chemotactic factors 
other than MCP-1 (in comparison with 
those that have infiltrated the kidney 
early in the disease process in response 
to MCP-1)? Furthermore, the analysis 
of macrophage properties in limited 
versus advanced disease and, possibly 
more importantly, of macrophages in 
areas of severe versus mild capillary 
loss in advanced disease should iden-
tify biomarkers that may help predict 
the progression of the underlying dis-
ease process.
Proteinuria, hypoxia, and the func-
tional properties of macrophages infil-
trating the kidney in chronic disease are 
critical for the outcome of the disease 
process, and one strength of the paper 
by Eardley et al.2 is that these have not 
been studied in isolation. This enabled 
the authors to speculate that the patchy 
nature of early disease, where macro-
phages localize to affected nephrons, 
is a consequence of localized increased 
production of MCP-1/CCL2 produced 
by tubular epithelial cells in response to 
albumin and other glomerular filtered 
proteins. They further suggest that 
in advanced disease, when nephron 
segments become scarred, ischemia 
becomes a dominant factor in further 
promoting macrophage infiltration and 
proliferation at these sites. These local 
processes will then involve bystander 
nephrons, with the development of 
both primary and secondary protein-
uria and ischemia (Figure 1). This 
raises the question of whether pro-
teinuria, even though it remains a sur-
rogate marker for disease progression, 
may be of less pathogenic relevance in 
late disease. Before we can elucidate 
these important questions, better tools 
to assess tissue hypoxia and its effects 
on different renal cell types, particu-
larly macrophages, are urgently needed. 
Nevertheless, once we have a better 
understanding of the effects of hypoxia 
and proteinuria on macrophage func-
tion, it is not inconceivable that the 
functional properties of macrophages 
in biopsies of patients with chronic 
kidney disease will provide important 
information to predict outcome and aid 
therapeutic decisions.
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figure 1 | The mechanism responsible for tissue damage in tubulointerstitial disease. In 
early renal disease, albuminuria induces monocyte chemoattractant protein-1 (MCP-1)/CCL2 
production by tubular endothelial cells, which in turn drives recruitment of proinflammatory 
macrophages. Disease progression leads to rarefaction of capillaries, tissue hypoxia, and 
activation of hypoxia-inducible genes, which then drive macrophage recruitment independent 
of MCP-1. These macrophages may, depending on their properties, lead to further disease 
progression or partial restoration of normal function.
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